Table 2.
Clinical presentation of both groups.
Types of symptoms and signs | Total patients n = 314 | Epi group n = 107 (34.1%) | Non-epi group n = 207 (65.9%) | p-value |
---|---|---|---|---|
Clinical presentation on arrival | ||||
Cardiovascular | ||||
Hypotension-no. (%) | 142 (45.2) | 61 (57.01) | 81 (39.1) | 0.03* |
Chest pain-no. (%)a | 30 (9.6) | 11 (10.3) | 19 (9.2) | 0.75 |
Cutaneous | ||||
Skin reaction-no. (%) | 273 (88.4) | 90 (84.1) | 183 (88.4) | 0.28 |
Angioedema-no. (%)a | 14 (4.5) | 6 (5.6) | 8 (3.9) | 0.57 |
Respiratory | ||||
Respiratory-no. (%) | 179 (57.0) | 58 (54.2) | 121 (58.5) | 0.47 |
Airway compromise-no. (%) | 50 (6.9) | 48 (44.9) | 2 (0.9) | <0.01* |
Gastrointestinal | ||||
N/V-no. (%) | 47 (15.0) | 13 (12.1) | 34 (16.4) | 0.31 |
Diarrhoea-no. (%)a | 16 (5.1) | 5 (4.7) | 11 (5.3) | 1.00 |
Neurological | ||||
Altered consciousness-no. (%) | 81 (25.8) | 58 (54.2) | 23 (11.1) | <0.01* |
Dizziness-no. (%)a | 23 (7.2) | 9 (8.4) | 14 (6.7) | 0.60 |
Continuous data are expressed as the means ± SDs, and categorical data are expressed as numbers (%).
Fisher’s exact test *p < 0.05 h, hour; N/V, nausea/vomiting.